Evidence map›Paper›PMID 26100841›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2015

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study.

Demetrios Simos, Christina Catley, Carl van Walraven, Angel Arnaout, Christopher M Booth, Matthew McInnes, Dean Fergusson, Susan Dent, Mark Clemons

Open access · goldAbstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Inappropriate use of clinical practices in Canada: a systematic review.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Physicians don't follow guidelines: What are we to do?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Investigations for patients with early-stage breast cancer: oversetting the stage.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Demetrios SimosDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Christina CatleyDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Carl van WalravenDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Angel ArnaoutDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Christopher M BoothDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Matthew McInnesDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Dean FergussonDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Susan DentDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont.
Mark ClemonsDivision of Medical Oncology, The Ottawa Hospital Cancer Centre (Simos, Dent, Clemons), Ottawa, Ont.; Department of Medicine (Simos, van Walraven, Fergusson, Dent, Clemons), University of Ottawa, Ottawa, Ont.; Ottawa Hospital Research Institute (Catley, van Walraven, Arnaout, McInnes, Fergusson, Clemons), Ottawa, Ont.; Institute for Clinical Evaluative Sciences (Catley, van Walraven), Toronto, Ont.; Department of Surgery (Arnaout) and Department of Radiology (McInnes), The Ottawa Hospital, Ottawa, Ont.; Department of Oncology (Booth), Queen's University, Kingston, Ont. mclemons@toh.on.ca.
Queen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPractice guidelines recommend that imaging to detect metastatic disease not be performed in the majority of patients with early-stage breast cancer who are asymptomatic. We aimed to determine whether practice patterns in Ontario conform with these recommendations.

methodsWe used provincial registry data to identify a population-based cohort of Ontario women in whom early-stage, operable breast cancer was diagnosed between 2007 and 2012. We then determined whether imaging of the skeleton, thorax, and abdomen or pelvis had been performed within 3 months of tissue diagnosis. We calculated rates of confirmatory imaging of the same body site.

resultsOf 26,547 patients with early-stage disease, 22,811 (85.9%) had at least one imaging test, and a total of 83,249 imaging tests were performed (mean of 3.7 imaging tests per patient imaged). Among patients with pathologic stage I and II disease, imaging was performed in 79.6% (10,921/13,724) and 92.7% (11,882/12,823) of cases, respectively. Of all imaging tests, 19,784 (23.8%) were classified as confirmatory investigations. Imaging was more likely for patients who were younger, had greater comorbidity, had tumours of higher grade or stage or had undergone preoperative breast ultrasonography, mastectomy or surgery in the community setting.

interpretationDespite recommendations from multiple international guidelines, most Ontario women with early-stage breast cancer underwent imaging to detect distant metastases. Inappropriate imaging in asymptomatic patients with early-stage disease is costly and may lead to harm. The use of population datasets will allow investigators to evaluate whether or not strategies to implement practice guidelines lead to meaningful and sustained change in physician practice.

Indexed as

Diagnostic ImagingGuideline AdherencePatient SelectionPractice Patterns, Physicians'AdultAgedAged, 80 and overAge FactorsBreast NeoplasmsCohort StudiesFemaleHumansMastectomyMiddle AgedNeoplasm StagingOntario

Identifiers

PMID26100841
PMCPMC4562856
OpenAlexW1887518047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.